Cue Biopharma, Inc. Public Float
Cue Biopharma, Inc. (CUE) had Public Float of $52.00 million as of 2025-06-30, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-16
- 2025-06-30: Entity Public Float $52.00M.
- 2024-06-28: Entity Public Float $59.90M.
- 2023-06-30: Entity Public Float $154.40M.
- 2022-06-30: Entity Public Float $82.10M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $52.00M 10-K · filed 2026-03-16 |
| 2024-06-28 | $59.90M 10-K · filed 2025-03-31 |
| 2023-06-30 | $154.40M 10-K · filed 2024-03-28 |
| 2022-06-30 | $82.10M 10-K · filed 2023-03-21 |
| 2021-06-30 | $362.60M 10-K · filed 2022-03-16 |
| 2020-06-30 | $695.10M 10-K · filed 2021-03-09 |
| 2019-06-28 | $160.40M 10-K · filed 2020-03-12 |
| 2018-06-29 | $216.40M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |